Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea

Background. Obstructive sleep apnoea (OSA) is related to type 2 diabetes (T2DM), and it may be associated with reduced inspiratory muscle strength (IMS). The aim of this study was to investigate the IMS in patients with T2DM, with or without OSA. Methods. Patients with T2DM with OSA (n=33) and witho...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas Rehling, Anne Margareta Banghøj, Marie Hvelplund Kristiansen, Lise Tarnow, Stig Molsted
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/4121794
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556427132010496
author Thomas Rehling
Anne Margareta Banghøj
Marie Hvelplund Kristiansen
Lise Tarnow
Stig Molsted
author_facet Thomas Rehling
Anne Margareta Banghøj
Marie Hvelplund Kristiansen
Lise Tarnow
Stig Molsted
author_sort Thomas Rehling
collection DOAJ
description Background. Obstructive sleep apnoea (OSA) is related to type 2 diabetes (T2DM), and it may be associated with reduced inspiratory muscle strength (IMS). The aim of this study was to investigate the IMS in patients with T2DM, with or without OSA. Methods. Patients with T2DM with OSA (n=33) and without OSA (n=28) were included. The maximum IMS was tested using the POWERbreathe KH2 device. Reference IMS values were data calculated using an algorithm based on general populations and adjusted for age and gender. Results. There was no difference in IMS between the OSA group (median (range) 77 (35–124) cmH2O) and the non-OSA group (84 (33–122) cmH2O) (p=0.97). The IMS values were reduced in the OSA group compared with the reference values (92.9 (62.3–100.0) cmH2O) (p=0.030), whereas the non-OSA group did not have reduced IMS. When the IMS values of all T2DM patients were compared with reference values, the IMS values were 79 (33–124) cmH2O and 93.8 (62.3–102.4) cmH2O, respectively (p=0.017). Conclusion. No difference in IMS between patients with T2DM with or without OSA was found. However, patients with T2DM and OSA had reduced IMS compared with age- and gender-matched references whereas the non-OSA group did not have reduced IMS.
format Article
id doaj-art-786738eb135145bea8db577325d38319
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-786738eb135145bea8db577325d383192025-02-03T05:45:25ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/41217944121794Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep ApnoeaThomas Rehling0Anne Margareta Banghøj1Marie Hvelplund Kristiansen2Lise Tarnow3Stig Molsted4University College (UCC) Department of Physiotherapy, Hillerød, DenmarkDepartment of Cardiology, Nephrology & Endocrinology, Nordsjællands Hospital, Hillerød, DenmarkDepartment of Cardiology, Nephrology & Endocrinology, Nordsjællands Hospital, Hillerød, DenmarkDepartment of Clinical Research, Nordsjællands Hospital, Hillerød, DenmarkDepartment of Cardiology, Nephrology & Endocrinology, Nordsjællands Hospital, Hillerød, DenmarkBackground. Obstructive sleep apnoea (OSA) is related to type 2 diabetes (T2DM), and it may be associated with reduced inspiratory muscle strength (IMS). The aim of this study was to investigate the IMS in patients with T2DM, with or without OSA. Methods. Patients with T2DM with OSA (n=33) and without OSA (n=28) were included. The maximum IMS was tested using the POWERbreathe KH2 device. Reference IMS values were data calculated using an algorithm based on general populations and adjusted for age and gender. Results. There was no difference in IMS between the OSA group (median (range) 77 (35–124) cmH2O) and the non-OSA group (84 (33–122) cmH2O) (p=0.97). The IMS values were reduced in the OSA group compared with the reference values (92.9 (62.3–100.0) cmH2O) (p=0.030), whereas the non-OSA group did not have reduced IMS. When the IMS values of all T2DM patients were compared with reference values, the IMS values were 79 (33–124) cmH2O and 93.8 (62.3–102.4) cmH2O, respectively (p=0.017). Conclusion. No difference in IMS between patients with T2DM with or without OSA was found. However, patients with T2DM and OSA had reduced IMS compared with age- and gender-matched references whereas the non-OSA group did not have reduced IMS.http://dx.doi.org/10.1155/2017/4121794
spellingShingle Thomas Rehling
Anne Margareta Banghøj
Marie Hvelplund Kristiansen
Lise Tarnow
Stig Molsted
Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea
Journal of Diabetes Research
title Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea
title_full Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea
title_fullStr Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea
title_full_unstemmed Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea
title_short Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea
title_sort reduced inspiratory muscle strength in patients with type 2 diabetes mellitus and obstructive sleep apnoea
url http://dx.doi.org/10.1155/2017/4121794
work_keys_str_mv AT thomasrehling reducedinspiratorymusclestrengthinpatientswithtype2diabetesmellitusandobstructivesleepapnoea
AT annemargaretabanghøj reducedinspiratorymusclestrengthinpatientswithtype2diabetesmellitusandobstructivesleepapnoea
AT mariehvelplundkristiansen reducedinspiratorymusclestrengthinpatientswithtype2diabetesmellitusandobstructivesleepapnoea
AT lisetarnow reducedinspiratorymusclestrengthinpatientswithtype2diabetesmellitusandobstructivesleepapnoea
AT stigmolsted reducedinspiratorymusclestrengthinpatientswithtype2diabetesmellitusandobstructivesleepapnoea